Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
2017 · New England Journal of Medicine · 2,229 citations
https://doi.org/10.1056/nejmoa1706198
T
Thomas W. Prior
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
243
Papers
19.9K
Citations
61
h-index
137
i10-index
Thomas W. Prior is an academic researcher from Johnson & Johnson (United States). The author has contributed to research in topics: Neurogenetic and Muscular Disorders Research & RNA modifications and cancer & Muscle Physiology and Disorders. The author has an h-index of 61, co-authored 207 publications.
Papers by this author
worksMidostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
2017 · New England Journal of Medicine · 2,152 citations
https://doi.org/10.1056/nejmoa1614359
Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
2005 · New England Journal of Medicine · 1,394 citations
https://doi.org/10.1056/nejmoa043146
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
2017 · Neuromuscular Disorders · 991 citations
https://doi.org/10.1016/j.nmd.2017.11.005
Natural history of denervation in SMA: Relation to age, <i>SMN2</i> copy number, and function
2005 · Annals of Neurology · 471 citations
https://doi.org/10.1002/ana.20473
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
2018 · Journal of Neuromuscular Diseases · 223 citations
https://doi.org/10.3233/jnd-180304
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat